New Buy Rating for Corteva (CTVA), the Basic Materials Giant
In a report released today, Benjamin Theurer from Barclays maintained a Buy rating on Corteva, with a price target of $91.00.
Introducing TipRanks MCP for Agents
- Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
- Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.
Theurer covers the Consumer Defensive sector, focusing on stocks such as Ingredion, Pilgrim’s Pride, and Coca Cola Femsa SAB De CV. According to TipRanks, Theurer has an average return of 4.6% and a 51.07% success rate on recommended stocks.
In addition to Barclays, Corteva also received a Buy from Morgan Stanley’s Vincent Andrews in a report issued on June 9. However, on the same day, UBS assigned a Hold rating to Corteva (NYSE: CTVA).
Based on Corteva’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $4.91 billion and a net profit of $720 million. In comparison, last year the company earned a revenue of $4.42 billion and had a net profit of $652 million
Read More on CTVA:
Disclaimer & DisclosureReport an Issue
- Corteva price target lowered to $86 from $90 at UBS
- Analyst Reiterates Buy on Corteva, Sees Market Underappreciating Growth with Unchanged $95 Price Target
- Corteva price target raised to $95 from $84 at Morgan Stanley
- Corteva headquarters its new companies in Indiana and Iowa
- Corteva price target raised to $90 from $88 at UBS
